Correction to: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer

Razia Rahman, Muhammed H. Rahaman, Adrienne R. Hanson, Nicholas Choo, Jianling Xie, Scott L. Townley, Raj Shrestha, Ramin Hassankhani, Saiful Islam, Susanne Ramm, Kaylene J. Simpson, Gail P. Risbridger, Giles Best, Margaret M. Centenera, Steven P. Balk, Ganessan Kichenadasse, Renea A. Taylor, Lisa M. Butler, Wayne D. Tilley, Simon J. ConnMitchell G. Lawrence, Shudong Wang, Luke A. Selth

Research output: Contribution to journalComment/debate

2 Downloads (Pure)

Abstract

Correction to: British Journal of Cancer (2024) 131:1092-1105; https://doi.org/10.1038/s41416-024-02810-8, published online 08 August 2024 In this article the title was incorrectly given as “CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer” but should have been “CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer”. The original article has been corrected.

Original languageEnglish
Pages (from-to)1719
Number of pages1
JournalBritish Journal of Cancer
Volume131
Issue number10
DOIs
Publication statusPublished - 30 Nov 2024

Keywords

  • Cyclin-dependent kinase 9 (CDK9)
  • oncogenic transcriptional pathways
  • epigenetic pathways
  • prostate cancer
  • immunohistochemistry

Fingerprint

Dive into the research topics of 'Correction to: CDK9 inhibition constrains multiple oncogenic transcriptional and epigenetic pathways in prostate cancer'. Together they form a unique fingerprint.

Cite this